Lv611
2270 积分 2022-10-17 加入
[2024 Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis]
2个月前
已完结
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
2个月前
已完结
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
2个月前
已完结
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
2个月前
已完结
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
2个月前
已完结
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
2个月前
已完结
Differences in response to Der p1 and bacterial lipopolysaccharide in peripheral blood mononuclear cells from severe and non-severe asthmatics
7个月前
已关闭
[Recommendations for diagnosis and treatment of systemic sclerosis in China]
7个月前
已完结
Overexpression of programmed death ligand 1 in refractory inflammatory bowel disease
9个月前
已完结
原发性IgA肾病管理和治疗中国专家共识
9个月前
已完结
皖公网安备34019202002308
